Listen Live

BRUNSWICK, N.J.  —  Johnson & Johnson is requesting the FDA grant emergency use authorization for its coronavirus vaccine.
The healthcare giant submitted that request Thursday.  Experts believe the vaccine could be approved by the end of February.
If it gets the go-ahead, it would be the third COVID-19 vaccine made available to the American public, following Pfizer and Moderna.
The single-dose vaccine is reportedly about 66-percent effective in preventing the virus and does not need to be kept in extreme cold storage.